Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookNational Drug Policy - Nigeria (FMOH, WHO; 2005; 32 pages)
View the documentFOREWORD
View the documentACKNOWLEDGEMENTS
View the documentACRONYMS
View the document1.0 INTRODUCTION
View the document2.0 DEFINITION
View the document3.0 GOALS OF THE NATIONAL DRUG POLICY
View the document4.0 OBJECTIVES OF THE NATIONAL DRUG POICY
View the document5.0. TARGETS OF THE NATIONAL DRUG POLICY
close this folder6.0 STRATEGIES FOR IMPLEMENTING THE NATIONAL DRUG POLICY
View the document6.1 SELECTION OF DRUGS
View the document6.2 PROCUREMENT OF DRUGS
View the document6.3 DRUG REVOLVING FUND SCHEME
View the document6.4 PRICING POLICY
View the document6.5 DRUG STORAGE
View the document6.6 DRUG DISTRIBUTION
Open this folder and view contents6.7 RATIONAL DRUG USE
View the document6.8 DONATED DRUGS
View the document6.9 LOCAL DRUG PRODUCTION
View the document6.10 LEGISLATION
View the document6.11 INSPECTION OF DRUGS
View the document6.12 IMPORTATION AND EXPORTATION OF DRUGS
View the document6.13 REGISTRATION OF DRUGS
View the document6.14 PATENTS
View the document6.15 QUALITY ASSURANCE
Open this folder and view contents6.16 REGULATIONS FOR PRESCRIBING AND DISPENSING DRUGS
View the document6.17 PHARMACOVIGILANCE
View the document6.18 DRUG INFORMATION AND PROMOTION
View the document6.19 DRUG FINANCING AND AFFORDABILITY
Open this folder and view contents6.20 RESEARCH AND DEVELOPMENT
View the document6.21 HERBAL AND OTHER TRADITIONAL REMEDIES
View the document6.22 HUMAN RESOURCES DEVELOPMENT
View the document6.23 CONTROL OF VETERINARY DRUGS
View the document6.24 INTERNATIONAL COOPERATION
View the document6.25 MONITORING AND EVALUATION
 

6.3 DRUG REVOLVING FUND SCHEME

The Drug Revolving Fund Scheme is a very effective strategy for ensuring uninterrupted drug supply in the health care delivery system. Experience from several health institutions in the country, however, has shown that its advantages have not been apparent due to a variety of reasons, including the following:

• poor management,
• misapplication of the Fund,
• purchasing of drugs at exorbitant prices,
• lumping of the proceeds of the Fund into a general account, and
• non-reimbursement of the cost of drugs for exempted patients.


Consequently, the Drug Revolving Fund Scheme shall be strengthened at all levels of government through:

i. Establishment of a DRF committee in every health institution for an effective and transparent fund management;

ii. Provision of adequate capital for the procurement of required drugs;

iii. Maintenance of a separate account for the DRF scheme, which shall be used exclusively for drug purchasing;

iv. Ensuring strict accountability for the drugs provided in the system by supplying them on a “cash-and-carry” basis;

v. Empowering the head of the pharmacy department of the health institution as the custodian of drugs to the institution and making him a required signatory to the DRF account; and

vi. Provision of appropriate training for the DRF personnel.

to previous sectionto next section

Please provide your feedback English  |  French